Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07380022

Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.

Led by University of Thessaly · Updated on 2026-02-02

100

Participants Needed

1

Research Sites

33 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective of the present postdoctoral research is to evaluate the acceptability and adherence of two dietary supplements containing microbial phytase, Goodphyte IB Defense and Goodphyte Immunity, in adult individuals with chronic diseases, namely Idiopathic Inflammatory Bowel Diseases (IIBD)-that is, Crohn's disease (CD) or Ulcerative Colitis (UC)-Arterial Hypertension (AH), Anemia (AN), or Multiple Sclerosis (MS). Secondarily, this study will investigate potential changes in iron and zinc absorption following phytase supplementation in these individuals and, consequently, possible changes in their quality of life.

CONDITIONS

Official Title

Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults with Crohn's disease in remission, stable treatment type for at least 3 months, stable dosage for the last month
  • Adults with Ulcerative colitis in remission, stable treatment type for at least 3 months, stable dosage for the last month
  • Adults with hypertension having systolic blood pressure 130-139 mmHg or diastolic blood pressure 80-89 mmHg, controlled by lifestyle changes without symptoms and no antihypertensive medication
  • Adults with anemia meeting defined hemoglobin, serum iron, and ferritin levels, with manageable fatigue, weakness, or dizziness and no severe clinical consequences
  • Adults with multiple sclerosis in remission, stable treatment type for at least 3 months, stable dosage for the last month
Not Eligible

You will not qualify if you...

  • Pregnancy or breastfeeding
  • Current use of antibiotics or antibiotic use within the past month
  • Current use of other probiotic, prebiotic, or synbiotic supplements
  • Current use of iron and/or zinc supplements
  • Change in pharmacological treatment type within the past three months
  • Change in pharmacological treatment dosage within the past month
  • Renal or hepatic disease
  • Inability to provide informed consent or younger than 18 years old
  • Insufficient understanding of the Greek language

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

School of Physical Education, Sport Science and Dietetics

Trikala, Thessaly, Greece, 42132

Actively Recruiting

Loading map...

Research Team

V

VAIOS SVOLOS, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases. | DecenTrialz